← Eichor
Condition: Fmt Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fmt

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05803980Fecal Microbial Transplantation for Rheumatoid Arthritis Trial
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05790356FMT in Initial CDI
NA · 1 location(s) · Turku University Hospital · NCT05257538Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
NA · 1 location(s) · Shanghai Zhongshan Hospital · NCT06388863Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
Phase 2 · 5 location(s) · Shenzhen Hospital of Southern Medical University · NCT06205862Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Phase 2 · 2 location(s) · Soroka University Medical Center · NCT05502913Intestinal Microbiome Transplant in ALS
Phase 1/Phase 2 · 1 location(s) · Duke University · NCT07017946Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
NA · 2 location(s) · Changhai Hospital · NCT07153809Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT03895593FMT to Convert Response to Immunotherapy
Phase 1/Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT05251389FMT Capsules for rCDI
Phase 3 · 1 location(s) · Helsinki University Central Hospital · NCT07458984Washed Microbiota Transplantation for Malnutrition
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT06447220Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bact
Phase 1/Phase 2 · 1 location(s) · University of Rijeka · NCT07106580Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
NA · 1 location(s) · Krunal Patel · NCT03562741Superdonor FMT in Patients With Ulcerative Colitis
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05739864Microbial Restoration in Inflammatory Bowel Diseases
Phase 1/Phase 2 · 1 location(s) · St Vincent's Hospital Melbourne · NCT04970446Fecal Microbiota Transplantation for Liver Failure
NA · 1 location(s) · Ningbo Medical Center Lihuili Hospital · NCT05170971Fecal Microbiota Transplant National Registry
Phase N/A · 53 location(s) · American Gastroenterological Association · NCT03325855FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis
Phase 2 · 1 location(s) · Hua Jiang · NCT06801665Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Phase 1 · 2 location(s) · McMaster Children's Hospital · NCT05967871Stool Transplants to Treat Refractory Clostridium Difficile Colitis
Phase 2 · 1 location(s) · Duke University · NCT02127398Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NA · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT04721041Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis
Phase 3 · 8 location(s) · Consorcio Centro de Investigación Biomédica en Red (CIBER) · NCT06533852Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Phase 2 · 7 location(s) · Michael Dill · NCT05690048Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · 20 location(s) · University Hospital, Clermont-Ferrand · NCT04935684Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
Phase 1 · 1 location(s) · University of Minnesota · NCT06370884FMT in Gut aGVHD Treated
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT03148743Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
NA · 1 location(s) · Asan Medical Center · NCT04264975Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
Phase 1 · 2 location(s) · University of Alberta · NCT07401680
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.